Advertise on podcast: Over the Counter sponsors by Drug Topics

Podcast episodes

Check latest episodes from Over the Counter podcast

Pharmacy Accreditation Requires Ongoing Diligence for Network Access

2026/04/23

Mitch Lamb, PharmD, joins Over the Counter to discuss pharmacy accreditation hurdles and why staying consistently proactive can mean the world for a pharmacy's bottom line.

What Pharmacies Need to Know About FDA Shift to 12-Digit NDCs

2026/04/16

Cencora representatives Matt Sample and Neal Cooper join Over the Counter to discuss the FDA's 7-year push to move national drug codes from 10 to 12 universal digits.

What the Walgreens ‘Hybrid Pharmacist’ Role is Doing for Workforces Challenges

2026/04/09

Walgreens Chief Pharmacy Officer Rick Gates joins Over the Counter to discuss his organization's newly introduced hybrid pharmacist role and how it is creating innovation across the greater pharmacy industry.

How Weight-Loss Drugs Could Reshape the Landscape of Addiction Treatment

2026/04/02

Sylvie Stacy, MD, MPH, joins Over the Counter to discuss the emerging evidence regarding GLP-1s for various types of substance use disorders and the potential role this medication class can play for millions of vulnerable patients.

Unpacking the FDA’s Sweeping Proposal to Move All Drugs to OTC

2026/03/26

Mark Garofoli, PharmD, BCGP, CPE, CTTS, joins Over the Counter to discuss recent comments from FDA Commissioner Marty Makary, MD, MPH, and what they could mean for the pharmacy profession going forward.

Diabetes Alert Day: The Pharmacist’s Powerful Role in Diabetes Care

2026/03/24

William A. Bryson, PharmD, joins Over the Counter for a bonus rendition celebrating Diabetes Alert Day on March 24.

A Pharmacist’s Look Into the Rise, Challenges of GLP-1 Compounding

2026/03/19

Annie Lambert, PharmD, BCSCP, joins Over the Counter to discuss the safety and scrutiny of compounded GLP-1s and the pharmacist's role in helping patients understand their clinical impact.

How Pharmacies Can Get Ahead of Persistent Drug Shortage Challenges

2026/03/12

Lani Bertrand, senior director of clinical marketing & thought leadership at Omnicell, joins Over the Counter to discuss the constant challenges pharmacies are faced with regarding drug shortages as well as the tools and approaches to overcome them.

DSCSA Compliance Updates for Independent Pharmacies in 2026

2026/03/05

Matt Sample, senior vice president of manufacturer, quality, and replenishment operations at Cencora, joins Over the Counter to discuss key updates under the DSCSA that independent pharmacies need to look out for in 2026.

Pharmacies Bridge the Diagnostic Dead Zone Through Health Monitoring, Diagnostic Testing

2026/02/26

Tim Drapeau, CEO of CLIAwaived Inc, joined Over the Counter to discuss the Test Yourself @ Home tool and how it is bridging care gaps between patients, pharmacists, and other providers.

Administrative Shifts in Vaccine Guidance and What Pharmacists Need to Know

2026/02/19

Jeff Goad, PharmD, MPH, joined Over the Counter to discuss ongoing developments regarding COVID-19 vaccines and the future of mRNA technology.

The Evolution of DTP Pharmacy Models and the Future of Digital Health

2026/02/12

Timothy Aungst, PharmD; Ravi Patel, PharmD, MBA, MS; and Smit Patel, PharmD; joined Over the Counter to discuss direct-to-patient pharmacy models and how they're revolutionizing the future of health care.

What the Newest Landmark PBM Reform Means for the Pharmacy Industry

2026/02/05

Jesse Dresser, Esq, joined Over the Counter to provide necessary insights into recently signed PBM reform set to revolutionize the distribution of pharmacy benefits.

Pharmacists Guide Patients as Prescription Drugs Move Over the Counter

2026/01/29

Alyssa Billingsley, PharmD, joined Over the Counter to discuss the FDA's prescription to OTC transition process and what recent switches mean for independent pharmacies and their patients.

IRA Drug Price Negotiations Threatening Pharmacies’ Financial Sustainability

2026/01/22

Chad Worz, PharmD, BCGP, FASCP, and James Lewis, from the American Society of Consultant Pharmacists (ASCP), joined Over the Counter to discuss the Inflation Reduction Act's industry-wide changes kicking off in 2026.